Rapaflo and Guaifenesin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rapaflo (silodosin) and Guaifenesin (guaifenesin). Common drug interactions include chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Rapaflo and Guaifenesin. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Rapaflo?

Rapaflo has active ingredients of silodosin. It is often used in prostate examination abnormal. eHealthMe is studying from 3,929 Rapaflo users. Check the latest studies of Rapaflo.

What is Guaifenesin?

Guaifenesin has active ingredients of guaifenesin. It is often used in cough. eHealthMe is studying from 12,106 Guaifenesin users. Check the latest studies of Guaifenesin.

On Jul, 09, 2026

13 people who take Rapaflo and Guaifenesin together, and have interactions are studied.

Rapaflo and Guaifenesin drug interactions.

What are the common drug interactions of Rapaflo and Guaifenesin, by gender? *:

female:

n/a

male:

Chronic kidney disease
Dizziness
Paranasal sinus discomfort
Rash pruritic (redness with itching)
Renal injury (kidney injury)
Respiratory tract infection
Skin cancer
Trismus (reduced opening of the jaws)
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Pneumonia

What are the common drug interactions of Rapaflo and Guaifenesin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Pneumonia
Pulmonary embolism (blockage of the main artery of the lung)

60+:

Chronic kidney disease
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
Paranasal sinus discomfort
Rash pruritic (redness with itching)
Renal injury (kidney injury)
Respiratory tract infection
Skin cancer
Trismus (reduced opening of the jaws)
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Cardiac failure

What are the existing conditions these people have? *

Pain: 4 people, 30.77%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 30.77%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 23.08%
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble): 2 people, 15.38%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 15.38%
Multiple Myeloma (cancer of the plasma cells): 2 people, 15.38%
Lymphoma (cancer that begins in immune system cells): 2 people, 15.38%
High Blood Pressure: 2 people, 15.38%
Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 15.38%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Rapaflo and Guaifenesin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously